Nov 12 |
AstraZeneca PLC (AZN) Q3 2024 Earnings Call Transcript
|
Nov 12 |
AstraZeneca Beats on Q3 Earnings, Ups 2024 View, to Invest $3.5B in US
|
Nov 12 |
AstraZeneca, Daiichi file for FDA accelerated approval of Dato-DXd
|
Nov 12 |
FTSE 100 drops to three-month low amid global sell-off
|
Nov 12 |
Merck, AstraZeneca report positive data for Koselugo in adults
|
Nov 12 |
Are dry powder inhalers the key to sustainable respiratory care?
|
Nov 12 |
AstraZeneca to spend $3.5B to expand U.S. operations
|
Nov 12 |
AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investigations 'Very Seriously'
|
Nov 12 |
Here's What Key Metrics Tell Us About Astrazeneca (AZN) Q3 Earnings
|
Nov 12 |
AstraZeneca Lifts Outlook, Plans $3.5B US Investment
|